James DArecca

Insider Reports History

Location
Boston, MA
Signature
/s/ James C. D'Arecca by Christine Sacco Attorney-in-Fact pursuant to Power of Attorney dated July 5, 2023 on file with the Commission
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by James DArecca:

Stock Role Class Num Shares Value Price $ Report Date Ownership
HAEMONETICS CORP EVP, Chief Financial Officer Common Stock 28.3K $1.96M $69.38 30 May 2025 Direct
TherapeuticsMD, Inc. Chief Financial Officer Restricted Stock Units 434K $1.58M $3.64 10 Aug 2021 Direct
Prestige Consumer Healthcare Inc. Director Common Stock, par value $0.01 per share 6.59K $518K $78.62 05 Aug 2025 Direct
TherapeuticsMD, Inc. Chief Financial Officer Common Stock 124K $277K $2.24 12 Aug 2021 Direct
HAEMONETICS CORP EVP, Chief Financial Officer Non-qualified Stock Option (Right to Buy) 15.4K 16 May 2025 Direct

Insider Reports Filed by James DArecca

Symbol Company Period Transactions Value $ Form Type Role Filing Time
PBH Prestige Consumer Healthcare Inc. 05 Aug 2025 1 $0 4 Director 06 Aug 2025, 16:02
HAE HAEMONETICS CORP 30 May 2025 2 -$407K 4 EVP, Chief Financial Officer 03 Jun 2025, 16:35
HAE HAEMONETICS CORP 16 May 2025 2 $0 4 EVP, Chief Financial Officer 20 May 2025, 17:14
HAE HAEMONETICS CORP 15 May 2025 2 -$131K 4 EVP, Chief Financial Officer 19 May 2025, 17:15
HAE HAEMONETICS CORP 02 May 2025 1 -$41.8K 4 EVP, Chief Financial Officer 05 May 2025, 16:16
PBH Prestige Consumer Healthcare Inc. 06 Aug 2024 1 $0 4 Director 07 Aug 2024, 16:04
HAE HAEMONETICS CORP 17 May 2024 2 $0 4 EVP, Chief Financial Officer 21 May 2024, 17:41
HAE HAEMONETICS CORP 15 May 2024 2 -$73K 4 EVP, Chief Financial Officer 17 May 2024, 16:52
HAE HAEMONETICS CORP 02 May 2024 1 -$40.3K 4 EVP, Chief Financial Officer 06 May 2024, 16:19
PBH Prestige Consumer Healthcare Inc. 01 Aug 2023 1 $0 4 Director 03 Aug 2023, 14:01
PBH Prestige Consumer Healthcare Inc. 01 Aug 2023 0 $0 3 Director 03 Aug 2023, 14:00
HAE HAEMONETICS CORP 15 May 2023 3 -$31.1K 4 EVP, Chief Financial Officer 17 May 2023, 16:26
HAE HAEMONETICS CORP 02 May 2023 1 -$35.1K 4 EVP, Chief Financial Officer 04 May 2023, 16:27
HAE HAEMONETICS CORP 16 May 2022 2 $0 4 EVP, Chief Financial Officer 18 May 2022, 16:34
HAE HAEMONETICS CORP 02 May 2022 2 $0 4 EVP, Chief Financial Officer 04 May 2022, 16:41
HAE HAEMONETICS CORP 11 Apr 2022 0 $0 3 EVP, Chief Financial Officer 14 Apr 2022, 16:29
TXMD TherapeuticsMD, Inc. 10 Aug 2021 3 -$81.2K 4 Chief Financial Officer 12 Aug 2021, 21:33
TXMD TherapeuticsMD, Inc. 01 Jul 2021 2 $0 4 CFO 02 Jul 2021, 17:45